Skip to content

Evaluation of a computer system that alerts heathcare professionals to changes in foetal monitoring signals acquired during labour

A randomised clinical trial of intrapartum foetal monitoring with computer analysis and alerts versus previously available monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42314164
Enrollment
8000
Registered
2009-01-26
Start date
2009-04-01
Completion date
Unknown
Last updated
2016-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrapartum foetal hypoxia Pregnancy and Childbirth Maternal care for other known or suspected fetal problems

Interventions

Continuous foetal monitoring during labour with computer analysis by the Omniview-SisPorto 3.5 system vs continuous intrapartum monitoring as previously performed.

Sponsors

University of Porto (Universidade do Porto) (Portugal)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women, aged more than 16 years 2. Able to provide written informed consent 3. Singleton pregnancy 4. Gestation of 36 or more completed weeks 5. Cephalic presentation 6. No known major foetal malformations 7. In active labour but not in active second stage 8. No known contraindication to vaginal delivery 9. Clinical decision made to perform continuous cardiotocography (CTG) monitoring

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Incidence of foetal metabolic acidosis, defined as newborn umbilical artery pH 12 mmol/L.

Secondary

MeasureTime frame
1. Overall rates of caesarean section and caesarean section for non-reassuring foetal state 2. Overall rates of instrumental vaginal delivery and instrumental vaginal delivery for non-reassuring foetal state 3. Foetal blood sampling rates 4. Incidence of 5-minute Apgar score <7 5. Need for neonatal intensive care unit admission 6. Incidence of moderate and severe neonatal encephalopathy with a hypoxic marker 7. Perinatal death 8. Rate of delayed interventions (interval between red alerts [intervention arm]/offline analysis [control arm] and delivery in metabolic acidosis cases) 8. Tracing quality and signal loss

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 30, 2026